Fortis Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Fortis Capital Management's RGEN Position: Q1 2024 in Review
Fortis Capital Management sold out of Repligen (RGEN) in Q1 2024, closing a stake of 9,300 shares — an estimated $1.67M sold.
Fortis Capital Management first reported a position in RGEN in Q3 2023 and held it in 2 quarters. The position peaked at $1.67M in Q4 2023. 487 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.
- Fortis Capital Management reported no remaining Repligen position as of Q1 2024 after selling out during the quarter.
- Fortis Capital Management sold 9,300 Repligen shares in Q1 2024, an estimated $1.67M.
- Fortis Capital Management first reported a position in Repligen in Q3 2023 and held it in 2 quarters.
- Fortis Capital Management's Repligen position peaked at $1.67M in Q4 2023.
- 487 funds tracked by Wall St. Rank held Repligen as of Q1 2024.
Based on Fortis Capital Management's 13F filing for Q1 2024, filed 30 Apr 2024.